ENETs/INCA Patient Symposium March 2018

ENETs Sim 3 picENETs/INCA Patient Symposium March 2018

A Joint
Effort by NET Patient and Medical Leaders to Identify and Address Issues That
Impede Optimal Care and Research

We are so grateful to the ENETs advisory board who for the
second year supported the INCA/ENETs join patient symposium as part of the main
scientific meeting. The number of participants was a significant increase on
last year which indicated the importance of hearing from patients. The key
areas covered were addressing the “patient information gap”, how can we improve
the information that is being delivered to patients at time of diagnosis and
throughout their treatment journey, how to improve access to treatments such as
PRRT and how to involve patients in research from trial design to clinical
trials. As so clearly put by Dr Ben Lawrence ‘….we would not design a treatment
plan without consulting the patient, thus we should not design research without
including the patient…..’

Speakers and panelists included:

Prof Martyn Caplin (Royal Free Hospital UK)

Simone Leyden (INCA President)

Ron Hollander (Past President of INCA)

Teodora Kolarova (Executive Director of INCA)

Kate Wakelin (NET Nurse Unicorn Foundation Aus)

Dr Ben Lawrence (Auckland NZ)

Josh Mailman (USA)

Cathy Bouvier (NET Patient Foundation UK)

For the full program please click here and we
look forward to reporting back next year on how these issues have been
addressed.

ENETs SIm 2 pic   ENETs Kate 3    ENETs Kate speaking     ENETs Sim pic   ENETs Kate 2   slide1    slide2    Slide3   Slide4   Slide5   Slide6

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Raising awareness of neuroendocrine cancer at Peninsula Bays Hospital Wellness Day

Raising Awareness for NETs on World Cancer Day in WA

Australia delivers excellent cancer care, but not equally

AUS-NET Update, January 2026

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.